Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, 27599, USA; Department of Pharmacology, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, 27599, USA.
Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, 27599, USA; Department of Pharmacology, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, 27599, USA; Department of Psychiatry, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, 27599, USA.
Neuropharmacology. 2020 Jun 15;170:108045. doi: 10.1016/j.neuropharm.2020.108045. Epub 2020 Mar 7.
The neuropeptide corticotropin-releasing factor (CRF) is critical in neural circuit function and behavior, particularly in the context of stress, anxiety, and addiction. Despite a wealth of preclinical evidence for the efficacy of CRF receptor 1 antagonists in reducing behavioral pathology associated with alcohol exposure, several clinical trials have had disappointing outcomes, possibly due to an underappreciation of the role of biological variables. Although he National Institutes of Health (NIH) now mandate the inclusion of sex as a biological variable in all clinical and preclinical research, the current state of knowledge in this area is based almost entirely on evidence from male subjects. Additionally, the influence of biological variables other than sex has received even less attention in the context of neuropeptide signaling. Age (particularly adolescent development) and housing conditions have been shown to affect CRF signaling and voluntary alcohol intake, and the interaction between these biological variables is particularly relevant to the role of the CRF system in the vulnerability or resilience to the development of alcohol use disorder (AUD). Going forward, it will be important to include careful consideration of biological variables in experimental design, reporting, and interpretation. As new research uncovers conditions in which sex, age, and environment play major roles in physiological and/or pathological processes, our understanding of the complex interaction between relevant biological variables and critical signaling pathways like the CRF system in the cellular and behavioral consequences of alcohol exposure will continue to expand ultimately improving the ability of preclinical research to translate to the clinic. This article is part of the special issue on Neuropeptides.
神经肽促肾上腺皮质释放因子(CRF)在神经回路功能和行为中起着至关重要的作用,特别是在应激、焦虑和成瘾的情况下。尽管有大量的临床前证据表明 CRF 受体 1 拮抗剂在减少与酒精暴露相关的行为病理学方面的有效性,但几项临床试验的结果令人失望,这可能是由于对生物变量作用的认识不足。尽管美国国立卫生研究院(NIH)现在要求在所有临床前和临床研究中都将性别作为生物变量纳入,但该领域的现有知识几乎完全基于来自男性受试者的证据。此外,在神经肽信号的背景下,除性别以外的生物变量的影响甚至受到更少的关注。年龄(特别是青少年发育)和居住条件已被证明会影响 CRF 信号和自愿饮酒量,这些生物变量之间的相互作用与 CRF 系统在易感性或对酒精使用障碍(AUD)的发展的弹性中的作用特别相关。今后,在实验设计、报告和解释中纳入对生物变量的仔细考虑将非常重要。随着新的研究揭示了性别、年龄和环境在生理和/或病理过程中起主要作用的条件,我们对相关生物变量与 CRF 系统等关键信号通路在酒精暴露的细胞和行为后果之间的复杂相互作用的理解将继续扩大,最终提高临床前研究转化为临床的能力。本文是神经肽特刊的一部分。